Malik; Asrar

Patent Applications and Registrations

Patent applications and USPTO patent grants for Malik; Asrar.The latest application filed is for "compositions and methods for diagnosing or treating neutrophil-mediated inflammatory disease".

Company Profile

3.4.9

Malik; Asrar - Hinsdale IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
KIF13B-derived peptide and method of inhibiting angiogenesis Grant 11,299,524 - Yamada , et al. April 12, 2	2022-04-12
Compositions And Methods For Diagnosing Or Treating Neutrophil-mediated Inflammatory Disease App 20210008003 - Wang; Zhenjia ; et al.	2021-01-14
Compositions And Methods For Diagnosing Or Treating Neutrophil-mediated Inflammatory Disease App 20190224139 - Wang; Zhenjia ; et al.	2019-07-25
Kif13b-derived Peptide And Method Of Inhibiting Angiogenesis App 20190169241 - YAMADA; Kaori ; et al.	2019-06-06
Compositions and methods for diagnosing or treating neutrophil-mediated inflammatory disease Grant 9,872,839 - Wang , et al. January 23, 2	2018-01-23
Compositions And Methods For Diagnosing Or Treating Neutrophil-mediated Inflammatory Disease App 20170143645 - Wang; Zhenjia ; et al.	2017-05-25
Compositions and methods for diagnosing or treating neutrophil-mediated inflammatory disease Grant 9,561,192 - Wang , et al. February 7, 2	2017-02-07
Flk1+ and VE-Cadherin+ Endothelial Cells Derived from iPS or ES Cells, and Methods of Preparing and Using the Same App 20160168538 - Wary; Kishore K. ; et al.	2016-06-16
Compositions And Methods For Diagnosing Or Treating Neutrophil-mediated Inflammatory Disease App 20150004242 - Wang; Zhenjia ; et al.	2015-01-01
Modulation Of Mlck-l Expression And Uses Thereof App 20110092568 - MEHTA; DOLLY ; et al.	2011-04-21
Modulation of MLCK-L expression and uses thereof Grant 7,825,101 - Mehta , et al. November 2, 2	2010-11-02
Modulation of MLCK-L Expression and Uses Thereof App 20100093830 - Mehta; Dolly ; et al.	2010-04-15
Methods and Compounds for Treating Inflammation App 20080160552 - Mehta; Dolly ; et al.	2008-07-03

Company Registrations

NCAGE Code	45X10	MALIK ASRAR
CAGE Code	45X10	MALIK, ASRAR

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.